HomeCompareSNCE vs PLD

SNCE vs PLD: Dividend Comparison 2026

SNCE yields 34.78% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.73M in total portfolio value· pulled ahead in Year 7
10 years
SNCE
SNCE
● Live price
34.78%
Share price
$5.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$26,108.19
Full SNCE calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — SNCE vs PLD

📍 PLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNCEPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNCE + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNCE pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNCE
Annual income on $10K today (after 15% tax)
$2,956.52/yr
After 10yr DRIP, annual income (after tax)
$22,191.96/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,015,924.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNCE + PLD for your $10,000?

SNCE: 50%PLD: 50%
100% PLD50/50100% SNCE
Portfolio after 10yr
$3.04M
Annual income
$2,388,416.69/yr
Blended yield
78.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SNCE
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
-3.2
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNCE buys
0
PLD buys
0
No recent congressional trades found for SNCE or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNCEPLD
Forward yield34.78%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$173.8K$5.91M
Annual income after 10y$26,108.19$4,750,725.19
Total dividends collected$125.1K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: SNCE vs PLD ($10,000, DRIP)

YearSNCE PortfolioSNCE Income/yrPLD PortfolioPLD Income/yrGap
1$14,178$3,478.26$11,241$540.96+$2.9KSNCE
2$19,780$4,608.94$13,019$991.13+$6.8KSNCE
3$27,173$6,009.16$15,801$1,870.97+$11.4KSNCE
4$36,791$7,715.34$20,609$3,701.21+$16.2KSNCE
5$49,129$9,762.64$29,919$7,867.97+$19.2KSNCE
6$64,752$12,183.73$50,631$18,617.74+$14.1KSNCE
7← crossover$84,292$15,007.57$105,528$51,352.20$21.2KPLD
8$108,451$18,258.34$287,364$174,449.42$178.9KPLD
9$137,997$21,954.52$1,081,760$774,280.77$943.8KPLD
10$173,765$26,108.19$5,908,209$4,750,725.19$5.73MPLD

SNCE vs PLD: Complete Analysis 2026

SNCEStock

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Full SNCE Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SNCE vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNCE vs SCHDSNCE vs JEPISNCE vs OSNCE vs KOSNCE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.